Pharmacology & Toxicology Faculty
Dr. Kaplan PhotoBarbara L.F. Kaplan, Assistant Professor
1992 BS, Environmental Toxicology, University of California-Davis
2001 PhD, Pharmacology and Toxicology, Michigan State University
2001-2004, Postdoctoral Research Associate, University of Chicago, Dept. Surgery
2004-present, Assistant Professor, Dept. Pharmacology & Toxicology, Michigan State University- Center of Integrated Toxicology



   Contact Info:Email: blkaplan@msu.edu Phone: (517) 884-2062 Fax: (517) 432-3218
Research Synopsis

The primary focus of my research is to determine the mechanism by which cannabinoid compounds (marijuana) suppress T cell function. Previously we have demonstrated that plant-derived cannabinoid compounds suppress the T cell growth factor interleukin-2 (IL-2) at the transcriptional level and that this inhibition involves decreased nuclear factor of activated T cell (NFAT) activity. Interestingly, in vitro, suppression of IL-2 does not occur via either of the currently cloned cannabinoid receptors, CB1 or CB2, suggesting that other receptors must be involved. With the current debate as to whether marijuana should be approved for medical use, it is critical to understand the effects of these compounds on the immune system.

Current Projects

Currently, I am characterizing the immune system effects of cannabidiol, a non-psychoactive plant-derived cannabinoid. This compound exhibits little affinity for either CB1 or CB2 yet its profile of activity in the immune system is similar to delta-9-tetrahydrocannabinol, the primary psychoactive congener of marijuana. Similar to other plant-derived cannabinoids, cannabidiol suppresses T cell function as measured by inhibition of IL-2 and interferon-gamma, inhibition of T cell proliferation and inhibition of the T cell-dependent antibody forming cell response. Future studies will focus on the effects of cannabidiol on immune function in vivo.

Achievements since 2001:

Michigan State University Respiratory Research Initiative Group Seed Grant, February, 2008

American Association of Immunologists Junior Faculty Travel Award , March, 2007

Michigan State University Respiratory Research Initiative Group Seed Grant, November, 2006

National Food Safety and Toxicology Center Research Expense Award, May, 2006

Publications since 2001:

Rockwell, Cheryl E., Raman, Priyadarshini, Kaplan, Barbara L.F., and Kaminski, Norbert E.  2008.  A COX-2 Metabolite of the Endogenous Cannabinoid, 2-Arachidonyl-Glycerol, Mediates Suppression of IL-2 Secretion in Activated Jurkat T Cells.  Biochem. Pharmacol.  In press.

Kaminski, Norbert E., Faubert Kaplan, Barbara L., and Holsapple, Michael P.  2007.  Toxic Responses of the Immune System.  In:  Casarett and Doull’s Toxicology 7th Edition (ed. C. D. Klaassen).  McGraw-Hill, New York.

Kaplan, Barbara L.F., Norell, Hakan, Callender, Glenda G., Ohlum, Tomas, Kiessling, Rolf, and Nishimura, Michael I.  2006.  Interferon-g Renders Tumors that Express Low Levels of Her-2/neu Sensitive to Cytotoxic T Cells.  Cancer Immunol. Immunother.  55:653.

Kaplan, Barbara L.F., Ouyang, Yanli, Rockwell, Cheryl, Rao, Gautham, and Kaminski, Norbert E.  2005.  Nuclear Factor of Activated T Cells (NF-AT) and Calcium Signaling are Involved in Suppression of Interferon-g (IFN-g) by the Endogenous Cannabinoid, 2-Arachidonyl-Glycerol.  J. Leuk Biol.  77:  966-974.

Kaplan, Barbara L.F., Moore, Tamson V., Schreiber, Karin, Callender, Glenda G., Schreiber, Hans and Nishimura, Michael I.  2005.  A New Murine Model for Studying Human HLA-A2-Restricted Tumor Immunity.  Cancer Lett.  224:  153-166.

Kaplan, Barbara L.F., Ouyang, Yanli, Herring, Amy, Yea, Sung Su, Razdan, Raj, and Kaminski, Norbert E.  2004.  Inhibition of Leukocyte Function and Interleukin-2 (IL-2) Gene Expression by 2-Methylarachidonyl-(2'-Fluoroethyl)Amide, a Stable Congener of the Endogenous Cannabinoid Receptor Ligand Anandamide.  2005Tox. Applied Pharmacol.  205:  107-115.

Kaplan, Barbara L. F., Yu, David C., Clay, Timothy M. and Nishimura, Michael I.  2003.  Redirecting T Lymphocyte Specificity Using T Cell Receptor Genes.  Int. Rev. Immunol.  22:  229-253.

Faubert Kaplan, Barbara L. and Kaminski, Norbert E.  2003. Cannabinoids Inhibit the Activation of ERK MAPK in PMA/Io-Stimulated Mouse Splenocytes.  Int. Immunopharmacol.  3:  1503-1510.

Faubert Kaplan, Barbara L, Rockwell, Cheryl E. and Kaminski, Norbert E.  2003.  Evidence for Cannabinoid Receptor-Dependent and –Independent Mechanisms of Action in Leukocytes.  J. Pharmacol. Exp. Ther.  306:  1077-1085.

Herring, Amy C., Faubert Kaplan, Barbara L. and Kaminski, Norbert E.  2001.  Modulation of CREB and NF-kB Signal Transduction by Cannabinol in Activated Thymocytes.  Cell. Signal.  13:  241-250.